Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

YA 101

Next Previous
Search
Drug Profile

YA 101

Alternative Names: YA-101

Latest Information Update: 04 Apr 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Yoda Pharmaceuticals
  • Class Anti-inflammatories
  • Mechanism of Action Neuronal plasticity modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Multiple system atrophy
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Multiple system atrophy

Most Recent Events

  • 26 Mar 2025 Phase-II clinical trials in Multiple system atrophy in USA (PO) (NCT06848231)
  • 04 Mar 2025 Yoda Therapeutics completes a phase-I clinical trials in Multiple system atrophy in Australia (unspecified route) prior to March 2025 (Yoda Therapeutics pipeline, March 2025)
  • 04 Mar 2025 Yoda Therapeutics plans a phase II trial for multiple system atrophy in the USA and Taiwan (NCT06848231)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top